Genes expression of metalloproteinases (MMP-1, MMP-2, MMP-9, and MMP-12) associated with psoriasis

Russian Journal of Genetics

Volumn 47, Issue 9, 2011, Pages 1117-1123

  Starodubtseva, N L ^a   Sobolev, V V ^b   Soboleva, A G ^b   Nikolaev, A A ^b   Bruskin, S A ^b  

^a MOSCOW INSTITUTE OF PHYSICS AND TECHNOLOGY   (Russian Federation)

^b VAVILOV INSTITUTE OF GENERAL GENETICS   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 17; MESSENGER RNA;

ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; GENE; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; KERATINOCYTE; MATRIX METALLOPROTEINASE 1 GENE; MATRIX METALLOPROTEINASE 12 GENE; MATRIX METALLOPROTEINASE 2 GENE; MATRIX METALLOPROTEINASE 9 GENE; PRIORITY JOURNAL; PSORIASIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; UPREGULATION;

EID: 80052824472     PISSN: 10227954     EISSN: 16083369     Source Type: Journal    
DOI: 10.1134/S102279541109016X     Document Type: Article

References (52)

1. Feng, B. J., Sun, L. D., Soltani-Arabshahi, R., et al., Multiple Loci within the Major Histocompatibility Complex Confer Risk of Psoriasis, PLoS Genet., 2009, vol. 5, no. 8, e1000606.
2. Zhang, X. J., Huang, W., Yang, S., et al., Psoriasis Genome-Wide Association Study Identifies Susceptibility Variants within LCE Gene Cluster at 1q21, Nat. Genet., 2009, vol. 41, no. 2, pp. 205-210.
3. Nair, R. P., Duffin, K. C., Helms, C., et al., Genome-Wide Scan Reveals Association of Psoriasis with IL-23 and NF-KappaB Pathways, Nat. Genet., 2009, vol. 41, no. 2, pp. 199-204.
4. Hollox, E. J., Huffmeier, U., Zeeuwen, P., et al., Psoriasis Is Associated with Increased Beta Defensin Genomic Copy Number, Nat. Genet., 2008, vol. 40, no. 2, pp. 23-25.
5. Galimova, E. S., Akhmetova, V. L., and Khusnutdinova, E. K., Molecular Genetic Bases of Susceptibility to Psoriasis, Russ. J. Genet., 2008, vol. 44, no. 5, pp. 594-605.
6. Chandran, V. and Raychaudhuri, S. P., Geoepidemiology and Environmental Factors of Psoriasis and Psoriatic Arthritis, J. Autoimmunity, 2010, vol. 34, pp. 314-321.
7. Lowes, M. A., Lew, W., Krueger, J. G., et al., Current Concepts in the Immunopathogenesis of Psoriasis, Dermatol. Clin., 2004, vol. 22, no. 4, pp. 349-369.
8. Hansson, G. K., Robertson, A. K., and Soederberg-Naucler, C., Inflammation and Atherosclerosis, Annu. Rev. Pathol., 2006, vol. 1, pp. 297-329.
9. Jiang, W. Y., Chattedee, A. D., Raychaudhuri, S. P., et al., Mast Cell Density and IL-8 Expression in Nonlesional and Lesional Psoriatic Skin, Int. J. Dermatol., 2001, vol. 40, no. 11, pp. 699-703.
10. Schoen, M. P. and Boehncke, W. H., Psoriasis, N. Engl. J. Med., 2005, vol. 352, no. 18, pp. 1899-1912.
11. Piruzyan, E. S., Nikol'skaya, T. A., Abdeev, R. M., et al., Components of the AP-1 Transcription Factor as Candidate Genes, Participating in the Development of Psoriasis, Mol. Biol. (Moscow), 2007, vol. 41, pp. 1069-1080.
12. Piruzyan, E. S., Sobolev, V. V., Abdeev, R. M., et al., Study of Molecular Mechanisms of Pathogenesis of Immunomediated Inflammatory Diseases by Example of Psoriasis, Acta Naturae, 2009, no. 3, pp. 139-150.
13. Piruzyan, E. S., Ishkin, A. A., Nikol'skaya, T. A., et al., Comparative Analysis of Molecular Genetic Processes in the Pathogeneses of Psoriasis and Crohn's Disease, Mol. Biol. (Moscow), 2009, no. 1, pp. 175-179.
14. Piruzian, E., Bruskin, S., Ishkin, A., et al., Integrated Network Analysis of Transcriptomic and Proteomic Data in Psoriasis, BMC Syst. Biol., 2010, vol. 4, pp. 2-24.
15. Parks, W. C., Wilson, C. L., Lopes-Boado, Y. S., et al., Matrix Metalloproteinases Modulators of Inflammation and Innate Immunity, Nat. Rev. Immunol., 2004, vol. 4, pp. 617-629.
16. Hijova, E., Matrix Metalloproteinases: Their Biological Function and Clinical Implications, Bratisl. Lek. Listy, 2005, vol. 106, no. 3, pp. 127-132.
17. Elkington, P. T., O'Kane, C. M., and Friedland, J. S., The Paradox of Matrix Metalloproteinases in Infectious Disease, Clin. Exp. Immunol., 2005, vol. 142, no. 1, pp. 12-20.
18. Manicone, A. M. and McGuire, K., Matrix Metalloproteinases as Modulators of Inflammation, Semin. Cell Dev. Biol., 2008, vol. 19, no. 1, pp. 34-41.
19. Dumin, J. A., Dickeson, S. K., Stricker, T. P., et al., Pro-Collagenase-1 (Matrix Metalloproteinase-1) Binds the Alpha(2)Beta(1) Integrin upon Release from Keratinocytes Migrating on Type I Collagen, J. Biol. Chem., 2001, vol. 276, no. 31, pp. 29368-29374.
20. McQuibban, G. A., Gong, J. H., Tam, E. M., et al., Imflammation Dampened by Gelatinase Cleavage of Monocyte Chemoattractant Protein-3, Science, 2000, vol. 289, no. 5482, pp. 1202-1206.
21. Zhang, K., McQuibban, G. A., Silva, C., et al., HIV-Induced Metalloproteinase Processing of the Chemokine Stromal Cell Derived Factor-1 Causes Neurodegeneration, Nat. Neurosci., 2003, vol. 6, no. 10, pp. 1064-1071.
22. Patterson, M. L., Atkinson, S. J., Knauper, V., et al., Specific Collagenolysis by Gelatinase A, MMP-2, Is Determined by the Hemopexin Domain and not the Fibronectin-Like Domain, FEBS Lett., 2001, vol. 503, nos. 2-3, pp. 158-162.
23. Murphy, G., McAlpine, C. G., Poll, C. T., et al., Purification and Characterization of a Bone Metalloproteinase That Degrades Gelatin and Types IV and V Collagen, Biochim. Biophys. Acta, 1985, vol. 831, no. 1, pp. 49-58.
24. Ito, A., Mukaiyama, A., Itoh, Y., et al., Degradation of Interleukin 1beta by Matrix Metalloproteinases, J. Biol. Chem., 1996, vol. 271, no. 25, pp. 14657-14660.
25. Yu, Q. and Stamenkovic, I., Cell Surface Localized Matrix Metalloproteinase-9 Proteolytically Activates TGF-Beta and Promotes Tumor Invasion and Angiogenesis, Genes Dev., 2000, vol. 14, no. 2, pp. 163-176.
26. Murphy, G. and Nagase, H., Progress in Matrix Metalloproteinase Research, Mol. Aspects Med., 2008, vol. 29, no. 5, pp. 290-308.
27. Kerkela, E., Bohling, T., Herva, R., et al., Human Macrophage Metalloelastase (MMP-12) Expression Is Induced in Chondrocytes during Fetal Development and Malignant Transformation, Bone, 2001, vol. 29, no. 5, pp. 487-493.
28. Hou, P., Troen, T., Ovejero, M. C., et al., Matrix Metalloproteinase-12 (MMP-12) in Osteoclasts: New Lesson on the Involvement of MMPs in Bone Resorption, Bone, 2004, vol. 34, no. 1, pp. 37-47.
29. Suomela, S., Kariniemi, A. L., Snellman, E., et al., Metalloelastase (MMP-12) and 92-kDa Gelatinase (MMP-9) as Well as Their Inhibitors, TIMP-1 and -3, Are Expressed in Psoriatic Lesions, Exp. Dermatol., 2001, vol. 10, no. 3, pp. 175-183.
30. Clark, I. M., Swingler, T. E., Sampieri, C. L., and Edwards, D. R., The Regulation of Matrix Metalloproteinases and Their Inhibitors, Int. J. Biochem. Cell Biol., 2008, vol. 40, nos. 6-7, pp. 1362-1378.
31. He, C., Molecular Mechanism of Transcriptional Activation of Human Gelatinase B by Proximal Promoter, Cancer Lett., 1996, vol. 106, no. 2, pp. 185-191.
32. Elliott, S. F., Coon, C. I., Hays, E., et al., Bcl-3 Is an Interleukin-1-Responsive Gene in Chondrocytes and Synovial Fibroblasts That Activates Transcription of the Matrix Metalloproteinase 1 Gene, Arthritis Rheum., 2002, vol. 46, pp. 3230-3239.
33. Livak, K. J. and Schmittgen, T. D., Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2(-Delta Delta C(T)) Method, Methods, 2001, vol. 25, no. 4, pp. 402-408.
34. Aljada, A., Ghanim, H., Mohanty, P., et al., Hydrocortisone Suppresses Intranuclear Activator-Protein-1 (AP-1) Binding Activity in Mononuclear Cells and Plasma Matrix Metalloproteinase 2 and 9 (MMP-2 and MMP-9), J. Clin. Endocrinol. Metab., 2001, vol. 12, pp. 5988-5991.
35. Karmakar, S. Dhar, R., and Das, C., Inhibition of Cytotrophoblastic (JEG-3) Cell Invasion by Interleukin 12 Involves an Interferon Gamma-Mediated Pathway, J. Biol. Chem., 2004, vol. 279, no. 53, pp. 55297-55307.
36. Bachmeier, B. E., Albini, A., Vene, R., et al., Cell Density-Dependent Regulation of Matrix Metalloproteinase and TIMP Expression in Differently Tumorigenic Breast Cancer Cell Lines, Exp. Cell Res., 2005, vol. 305, no. 1, pp. 83-98.
37. Hasegawa Hitoki, Senga Takeshi, Ito Satoko, et al., A Role for AP-1 in Matrix Metalloproteinase Production and Invadopodia Formation of v-Crk-Transformed Cells, Exp. Cell Res., 2009, vol. 315, no. 8, pp. 1384-1392.
38. Fanjul-Fernandez, M., Folgueras, A. R., Cabrera, S., and Lopez-Otin, C., Matrix Metalloproteinases: Evolution, Gene Regulation and Functional Analysis in Mouse Models, Biochim. Biophys. Acta, 2010, vol. 1803, no. 1, pp. 3-19.
39. Singh, N. K., Quyen, D. V., Kundumani-Sridharan, V., et al., AP-1 (Fra-1/C-Jun)-Mediated Induction of Expression of Matrix Metalloproteinase-2 Is Required for 15S-Hydroxyeicosatetraenoic Acid-Induced Angiogenesis, J. Biol. Chem., 2010, vol. 285, no. 22, pp. 16830-16843.
40. Ni, J., Waldman, A., and Khachigian, L. M., C-Jun Regulates Shear- and Injury-Inducible Egr-1 Expression, Vein Graft Stenosis after Autologous End-to-Side Transplantation in Rabbits, and Intimal Hyperplasia in Human Saphenous Veins, J. Biol. Chem., 2010, vol. 285, no. 6, pp. 4038-4048.
41. Xie, T. X., Wei, D., Liu, M., et al., Stat3 Activation Regulates the Expression of Matrix Metalloproteinase-2 and Tumor Invasion and Metastasis, Oncogene, 2004, vol. 23, pp. 3550-3560.
42. Baker, S. J., Rane, S. G., and Reddy, E. P., Hematopoietic Cytokine Receptor Signaling, Oncogene, 2007, vol. 26, no. 47, pp. 6724-6737.
43. Bergman, M. R., Cheng, S., Honbo, N., et al., A Functional Activating Protein 1 (AP-1) Site Regulates Matrix Metalloproteinase 2 (MMP-2) Transcription by Cardiac Cells through Interactions with JunB-Fra1 and JunB-FosB Heterodimers, Biochem. J., 2003, vol. 369, pp. 485-496.
44. Lee, J. G., Dahi, S., Mahimkar, R., et al., Intronic Regulation of Matrix Metalloproteinase-2 Revealed by in vivo Transcriptional Analysis in Ischemia, Proc. Natl. Acad. Sci. USA, 2005, vol. 102, pp. 16345-16350.
45. Yan, C. and Boyd, D. D., Regulation of Matrix Metalloproteinase Gene Expression, J. Cell Physiol., 2007, vol. 211, pp. 19-26.
46. Schreiber, M., Wang, Z. Q., Jochum, W., et al., Placental Vascularisation Requires the AP-1 Component Fra1, Development, 2000, vol. 127, no. 22, pp. 937-948.
47. Sobolev, V. V., Zolotarenko, A. D., Soboleva, A. G., et al., Effects of Expression of Transcriptional Factor AP-1 FOSL1 Gene on Psoriatic Process, Byull. Eksp. Biol. Med., 2010, vol. 150, pp. 564-567.
48. Sobolev, V. V., Zolotorenko, A. D., Soboleva, A. G., et al., Expression of the FOSL1 Gene in Psoriasis and Atherosclerosis, Russ. J. Genet., 2010, vol. 46, no. 1, pp. 104-110.
49. Fanjul-Fernndez, M., Folgueras, A. R., Cabrera, S., et al., Matrix Metalloproteinases: Evolution, Gene Regulation and Functional Analysis in Mouse Models, Biochim. Biophys. Acta, 2010, vol. 1803, no. 1, pp. 3-19.
50. Flisiak, I., Zaniewski, P., and Chodynicka, B., Plasma TGF-Beta1, TIMP-1, MMP-1 and IL-18 as a Combined Biomarker of Psoriasis Activity, Biomarkers, 2008, vol. 13, no. 5, pp. 549-556.
51. Flisiak, I., Porebski, P., and Chodynicka, B., Effect of Psoriasis Activity on Metalloproteinase-1 and Tissue Inhibitor of Metalloproteinase-1 in Plasma and Lesional Scales, Acta Dermatol. Venereol., 2006, vol. 86, no. 1, pp. 17-21.
52. Suomela, S., Kariniemi, A. L., Snellman, E., et al., Metalloelastase (MMP-12) and 92-kDa Gelatinase (MMP-9) as Well as Their Inhibitors, TIMP-1 and -3, Are Expressed in Psoriatic Lesions, Exp. Dermatol., 2001, vol. 10, no. 3, pp. 175-183.